Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
Top Cited Papers
- 1 July 2001
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 358 (9275), 24-29
- https://doi.org/10.1016/s0140-6736(00)05252-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α‐chain variant in an English familyQJM: An International Journal of Medicine, 2000
- Behçet’s Disease and AA-Type AmyloidosisAmerican Journal of Nephrology, 2000
- The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patientsGut, 1998
- Complete Clinical Remission and Subsequent Relapse of Bronchiectasis-Related (AA) Amyloid Induced Nephrotic SyndromeNephron, 1996
- The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.Journal of Clinical Investigation, 1994
- Serum amyloid p component scintigraphy and turnover studies for diagnosis and quantitative monitoring of aa amyloidosis in juvenile rheumatoid arthritisArthritis & Rheumatism, 1993
- Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.Journal of Clinical Investigation, 1990
- A primed state exists in vivo following histological regression of amyloidosisClinical and Experimental Immunology, 1990
- DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENTThe Lancet, 1988
- Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.The Journal of Experimental Medicine, 1988